Metabolic predictors and vitamin D deficiency in patients with type 2 diabetes mellitus


  • M.B. Aludwan PhD Student at the Department of Endocrinology, Bogomolets National Medical University, T. Shevchenko boulevard, 13, Kyiv, 02000, Ukraine
  • N.M. Kobylіak Associate Professor at the Department of Endocrinology, Bogomolets National Medical University, T. Shevchenko boulevard, 13, Kyiv, 02000, Ukraine
  • Yu.I. Komisarenko MD, PhD, Professor at the Department of Endocrinology, Bogomolets National Medical University, T. Shevchenko boulevard, 13, Kyiv, 02000, Ukraine



vitamin D, type 2 diabetes mellitus, insulin resistance, β-cell function, obesity


Background. Recently, vitamin D deficiency is considered one of the factors for the development of type 2 diabetes mellitus. The purpose of this study was to eva­luate changes in anthropometric parameters, indicators of carbohydrate and lipid metabolism in patients with type 2 diabetes mellitus depending on vitamin D status. Materials and methods. According to the recommendations of the European Society of Endocrinology, all patients were divided into 3 groups: group 1 — optimal vitamin D level (30 ng/ml); group 2 — vitamin D deficiency (21–29 ng/ml); and group 3 — vitamin D deficiency (< 20 ng/ml). Insulin sensiti­vity and β-cell functional activity were evaluated using the HOMA-2 calculator. Results. The ave­rage body mass index increased in parallel with a decrease in the serum vitamin D concentration. The highest body mass index and prevalence of obesity, including morbid obesity (16.7 %), were observed in the vitamin D deficiency group. HOMA-2-IR (2.12 ± 0.71 vs 2.25 ± 0.95, p = 0.963) and insulin sensitivity (S% — 57.11 ± 32.07 vs 54.69 ± 32.5, p = 0.965) in the group of the optimal level of vitamin D and its insufficiency (group 2) were almost identical. In vitamin D deficiency, HOMA-2-IR was statistically significantly higher — by 46.2 % (p = 0.004), and insulin sensitivity was by 27.5 % lower (p = 0.027). The functional activity of β-cells did not change statistically significantly between all groups, regardless of the vitamin D status. An inverse correlation was established between the concentrations of vitamin D and glycated hemoglobin, HOMA-2-IR, C-peptide and S%. Among the parameters of lipid metabolism in the vitamin D deficiency group, a statistically significantly higher level of triglycerides and very low density lipoproteins was found. In the correlation and regression analysis, insulin resistance parameters, glycemic control indices, lipid profiles and metformin intake were independently associated with vitamin D deficiency. Conclusions. Vitamin D deficiency in patients with type 2 diabetes mellitus is associated with more pronounced insulin resistance, obesity and inadequate glycemic control compared to the optimal level or its insufficiency.


Download data is not yet available.


International Diabetes Federation. IDF Diabetes Atlas. 6th ed. 2013. Available from:

Mechanick JI. Global dimensions of diabetes information and synthesis. Ann Glob Health. 2015 Nov-Dec;81(6):733-4. doi: 10.1016/j.aogh.2015.12.015.

Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Kyriienko D, Komissarenko I. Effect of alive probiotic on insulin resistance in type 2 diabetes patients. Randomized clinical trial. Diabetes Metab Syndr. 2018 Sep;12(5):617-624. doi: 10.1016/j.dsx.2018.04.015.

Pankiv VI. Association between metformin use and vitamin B12 deficiency in patients with type 2 diabetes. Mìžnarodnij endokrinologìčnij žurnal. 2019;15(1):47-54. doi: 10.22141/2224-0721.15.1.2019.158691. (in Ukrainian).

Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes. 2019 Mar 15;10(3):154-168. doi: 10.4239/wjd.v10.i3.154.

Mykhalchyshyn G, Kobyliak N, Bodnar P. Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Metab Disord. 2015 May 19;14:44. doi: 10.1186/s40200-015-0170-1.

Pankiv VI. Disorders of carbohydrate metabolism in clinical practice. Mìžnarodnij endokrinologìčnij žurnal. 2017;13(1):39-44. doi: 10.22141/2224-0721.13.1.2017.96754. (in Ukrainian).

James WP. 22nd Marabou Symposium: the changing faces of vitamin D. Nutr Rev. 2008 May;66(5):286-90. doi: 10.1111/j.1753-4887.2008.00034.x.

Malhotra N, Mithal A, Gupta S, Shukla M, Godbole M. Effect of vitamin D supplementation on bone health parameters of healthy young Indian women. Arch Osteoporos. 2009 Dec;4(1-2):47-53. doi: 10.1007/s11657-009-0026-8.

Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000 Aug;72(2):472-5. doi: 10.1093/ajcn/72.2.472.

Van der Meer IM, Boeke AJ, Lips P, et al. Fatty fish and supplements are the greatest modifiable contributors to the serum 25-hydroxyvitamin D concentration in a multiethnic population. Clin Endocrinol (Oxf). 2008 Mar;68(3):466-72. doi: 10.1111/j.1365-2265.2007.03066.x.

Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007 Jun;92(6):2058-65. doi: 10.1210/jc.2006-1525.

Fradinger EE, Zanchetta JR. Vitamin D status in women living in Buenos Aires. Medicina (B Aires). 1999;59(5 Pt 1):449-52. (in Spanish).

Kaminskyi OV, Pankiv VI, Pankiv IV, Afanasyev DE. Vitamin D content in population of radiologically contaminated areas in Chernivtsi region (pilot project). Probl Radiac Med Radiobiol. 2018 Dec;23:442-451. doi: 10.33145/2304-8336-2018-23-442-451.

Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 Mar 19;338(12):777-83. doi: 10.1056/NEJM199803193381201.

Pasco JA, Henry MJ, Nicholson GC, Sanders KM, Kotowicz MA. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust. 2001 Oct 15;175(8):401-5.

Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001 Nov 3;358(9292):1500-3. doi: 10.1016/S0140-6736(01)06580-1.

Al-Shoumer KA, Al-Essa TM. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus? World J Diabetes. 2015 Jul 25;6(8):1057-64. doi: 10.4239/wjd.v6.i8.1057.

Komisarenko YI, Bobryk MI. Vitamin D Deficiency and Immune Disorders in Combined Endocrine Pathology. Front Endocrinol (Lausanne). 2018 Oct 9;9:600. doi: 10.3389/fendo.2018.00600.

Mazanova A, Shymanskyi I, Lisakovska O, Hajiyeva L, Komisarenko Y, Veliky M. Effects of Cholecalciferol on Key Components of Vitamin D-Endo Para Autocrine System in Experimental Type 1 Diabetes. Int J Endocrinol. 2018 Feb 6;2018:2494016. doi: 10.1155/2018/2494016.

American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(1):13-27. doi: 10.2337/dc18-S002.

Cobas. E411 Vitamin D Total Reagent Insert (06268668001V1). Available from: Accessed: 19 March 2019.

Abdel-Wareth L, Haq A, Turner A, et al. Total vitamin D assay comparison of the Roche Diagnostics "Vitamin D total" electrochemiluminescence protein binding assay with the Chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D. Nutrients. 2013 Mar 22;5(3):971-80. doi: 10.3390/nu5030971.

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. doi: 10.1210/jc.2011-0385.

Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):106-20. doi: 10.1016/j.mce.2011.08.016.

Park SK, Garland CF, Gorham ED, Budoff L, Barrett-Connor E. Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PLoS One. 2018 Apr 19;13(4):e0193070. doi: 10.1371/journal.pone.0193070.

Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J. 2010 Mar;103(3):265-7. doi: 10.1097/SMJ.0b013e3181ce0e4d.

Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012 Sep;97(3):359-67. doi: 10.1016/j.diabres.2012.06.001.

Kos E, Liszek MJ, Emanuele MA, Durazo-Arvizu R, Camacho P. Effect of metformin therapy on vitamin D and vitamin B levels in patients with type 2 diabetes mellitus. Endocr Pract. 2012 Mar-Apr;18(2):179-84. doi: 10.4158/EP11009.OR.

Alkharfy KM, Al-Daghri NM, Sabico SB, et al. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol. 2013 Aug 7;12:113. doi: 10.1186/1475-2840-12-113.



How to Cite

Aludwan, M., Kobylіak N., & Komisarenko, Y. (2021). Metabolic predictors and vitamin D deficiency in patients with type 2 diabetes mellitus. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 15(6), 459–468.



Original Researches